FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, with this version being a nasal spray as opposed to an injection. The vaccine FluMist,
US approves first nasal spray flu vaccine that can be self-administered
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a health care provider.
MedImmune Receives FDA Approval for Self-Administered Flu Vaccine
AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.
FDA Approves First At-Home Nasal Flu Vaccine
The FDA has OK'd FluMist, a nasal spray flu vaccine that you can give and get at home – no health care provider needed. It’s the first flu vaccine of its kind, offering a simple, convenient, needle-free option that its maker hopes will improve access and uptake.
FDA approves at-home FluMist administration
Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility assessment when they order the vaccine.
FDA approves first flu vaccine that can be self-administered at home
"For those interested in self or caregiver administration, the vaccine manufacturer plans to make the vaccine available through a third-party online pharmacy," the FDA said. "Those who choose this option will complete a screening and eligibility assessment when they order FluMist.
MedImmune Receives FDA Approval for Self-Administered Flu Vaccine
AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider. FluMist ...
FDA approves first self administered flu vaccine as nasal spray
The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is approved for the prevention of influenza disease caused by influenza
pharmaphorum10y
MedImmune completes $500m acquisition of Amplimmune
AstraZeneca's global biologics research and development arm, MedImmune, has completed its acquisition of Amplimmune, in a deal worth up to US $500 million. Amplimmune is a US-based biologics ...
The News Journal4y
Pipeline full as MedImmune celebrates founding
When AstraZeneca acquired MedImmune in 2007 for $15 billion, some analysts felt the firm overpaid for the biotech company. This week, MedImmune celebrates its 25th anniversary – and has come to ...
Daily Jang2d
FDA signals green light to game-changing flu vaccine spray
The FDA has approved the game-changing first flu vaccine spray that can be self-administered!On Friday, September 20, the ...
cidrap.umn4d
Minnesota reports 2 H3N2v flu infections in fairgoers
The Minnesota Department of Health has reported two variant H3N2 (H3N2v) flu infections, both involving young people who ...